We found that Trp complex isolated from CT26 cells pretreated with BCI‐137 does not inhibit CT26 growth, suggesting that Ago2 is indeed involved in the Trp complex mediated inhibition of CT26 tumor cell growth (Figure S3A, Supporting Information). Here, DDX53 is linked to neoplasm.